SEC Contract Filing

Filing Date: 2024-06-18

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d853800dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="right"><B>Exhibit 10.1</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><U>ENLIVEN THERAPEUTICS, INC. </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri" ALIGN="center"><U>AMENDED AND
RESTATED 2020 EQUITY INCENTIVE PLAN </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri">1. <U>Purpose</U>. The purpose of this Amended and Restated 2020 Equity Incentive Plan (the
&#147;<B><I>Plan</I></B>&#148;) of Enliven Therapeutics, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), is to advance the interests of the Company&#146;s stockholders by enhancing the Company&#146;s ability to attract, retain
and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and <FONT STYLE="white-space:nowrap">performance-based</FONT> incentives that are intended to
better align the interests of such persons with those of the Company&#146;s stockholders. The Plan amends and restates the 2020 Equity Incentive Plan (the &#147;<B><I>Original Plan</I></B>&#148;) that was originally adopted by the board of directors
of the Company (the &#147;<B><I>Board</I></B>&#148;) on February&nbsp;12, 2020 and approved by the stockholders on February&nbsp;26, 2020. Except where the context otherwise requires, the term &#147;<B><I>Company</I></B>&#148; shall include any of
the Company&#146;s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f)&nbsp;of the Internal Revenue Code of 1986, as amended, and any regulations thereunder (the &#147;<B><I>Code</I></B>&#148;) and any other
business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as determined by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri">2. <U>Eligibility</U>. All of the Company&#146;s employees, officers and directors, as well as consultants and advisors to the Company (as such terms
consultants and advisors are defined and interpreted for purposes of Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;), or any successor form) are eligible to
be granted Awards (as defined below) under the Plan. Each person who is granted an Award under the Plan is deemed a &#147;<B><I>Participant</I></B>.&#148; &#147;<B><I>Award</I></B>&#148; means Options (as defined in Section&nbsp;5), SARs (as defined
in Section&nbsp;6), Restricted Stock (as defined in Section&nbsp;7), Restricted Stock Units (as defined in Section&nbsp;7) and Other <FONT STYLE="white-space:nowrap">Stock-Based</FONT> Awards (as defined in Section&nbsp;8). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Calibri">3. <U>Administration and Delegation</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri">(a)
<U>Administration by Board of Directors</U>. The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it
shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in
the manner and to the extent it shall deem expedient and it shall be the sole and final judge of such expediency. All actions and decisions by the Board with respect to the Plan and any Awards shall be made in the Board&#146;s sole discretion and
shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri">(b) <U>Appointment of Committees</U>. To
the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (each, a &#147;<B><I>Committee</I></B>&#148;). All references in the Plan to the
&#147;<B><I>Board</I></B>&#148; shall mean the Board or a Committee of the Board or the Delegated Persons referred to in Section&nbsp;3(c) to the extent that the Board&#146;s powers or authority under the Plan have been delegated to such Committee
or such Delegated Persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Calibri">(c) <U>Dele</U>g<U>ation to Delegated Persons</U>. Subject to any requirements of applicable law (including as
applicable Sections 152(b) and 157(c) of the General Corporation Law of the State of Delaware), the Board may, by resolution, delegate to one or more persons (including officers of the Company) or bodies (such persons or bodies, the
&#147;<B><I>Delegated Persons</I></B>&#148;) the power to grant Awards (subject to any limitations under the Plan) to eligible service providers of the Company and to exercise such other powers under the Plan as the Board may determine, provided
that the Board shall fix: (i)&nbsp;the maximum number of Awards, and the maximum number of shares issuable upon exercise thereof, that may be issued by such Delegated Persons, (ii)&nbsp;the time period during which such Awards, and during which the
shares issuable upon exercise thereof, may be issued, and (iii)&nbsp;the